Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors.
about
Next Generation Sequencing of Actinobacteria for the Discovery of Novel Natural ProductsEnzyme Inhibition by Hydroamination: Design and Mechanism of a Hybrid Carmaphycin-Syringolin Enone Proteasome InhibitorMass spectrometry of natural products: current, emerging and future technologiesMultiplexed metagenome mining using short DNA sequence tags facilitates targeted discovery of epoxyketone proteasome inhibitorsIdentifying the Minimal Enzymes Required for Biosynthesis of Epoxyketone Proteasome Inhibitors.Using Molecular Networking for Microbial Secondary Metabolite Bioprospecting.Discovery of microbial natural products by activation of silent biosynthetic gene clusters.Comparative mass spectrometry-based metabolomics strategies for the investigation of microbial secondary metabolites.The evolution of genome mining in microbes - a review.Biosynthesis of the β-Lactone Proteasome Inhibitors Belactosin and Cystargolide.Epoxomicin and Eponemycin Biosynthesis Involves gem-Dimethylation and an Acyl-CoA Dehydrogenase-Like Enzyme.Prioritizing Natural Product Diversity in a Collection of 146 Bacterial Strains Based on Growth and Extraction Protocols.Generate a bioactive natural product library by mining bacterial cytochrome P450 patterns.Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors.Oxidative coupling of 1-(2-methyl-4-phenylquinolin-3-yl)ethanone with ethanol and unexpected deacetylative synthesis of 3-hydroxy quinoline.
P2860
Q26752751-1C12FB2C-AD12-49CC-A518-652FA4FFF581Q27684346-81858541-B021-4AB2-8B4B-BD413B99F2F0Q34165224-5E56E8EF-331F-4A20-AD7D-16981BE568EDQ35378769-1EF184F3-4C8E-43D4-9221-06ED08A6903BQ36469865-8BC1424A-8465-4DDA-846E-11678D39D66BQ36741597-CE0A8F3A-5D54-4A55-9673-9A4483AC385EQ38539563-A4FDD1CB-48C4-4DF8-870A-ED6270BF42DBQ38823592-46A5F4B0-8FAE-4EB5-8E19-D0B0E82EA0BAQ38858040-7DE1E344-1B4E-4B35-86BE-D04E4326ACC0Q40234235-71264230-261E-45FD-A253-BA09901C1D81Q40825366-8C5B4B23-7BF7-4837-82BC-A66BE2B7A2B9Q42372496-CED51410-DD1B-4871-B163-717B16EB4AC2Q45269243-30B638D8-9E5D-43E1-A926-21ABCFD799A2Q48165004-8EAE54F8-140D-4BFF-8BF5-E3F253A38656Q48373511-34FCAA31-BBBC-40D6-AEFF-8AE7AE0A7616
P2860
Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genetic basis for the biosynth ...... yketone proteasome inhibitors.
@ast
Genetic basis for the biosynth ...... yketone proteasome inhibitors.
@en
type
label
Genetic basis for the biosynth ...... yketone proteasome inhibitors.
@ast
Genetic basis for the biosynth ...... yketone proteasome inhibitors.
@en
prefLabel
Genetic basis for the biosynth ...... yketone proteasome inhibitors.
@ast
Genetic basis for the biosynth ...... yketone proteasome inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Genetic basis for the biosynth ...... xyketone proteasome inhibitors
@en
P2093
Joseph P Noel
Judith Zettler
Leonard Kaysser
Michelle Schorn
Pieter C Dorrestein
P2860
P304
P356
10.1021/CB400699P
P577
2013-11-08T00:00:00Z